Rt Capital Management investment portfolio

Iota Sciences develops and supplies automated microfluidics platforms for gentle single‑cell isolation, cloning and low‑volume cell culture, together with cell‑line engineering services focused on human induced pluripotent stem cells, serving researchers in cell‑biology, CRISPR‑Cas9 gene‑editing, single‑cell omics and antibody discovery.

Navenio delivers an infrastructure‑free indoor location platform that uses existing smartphones to provide real‑time, room‑level positioning of people, staff and equipment. Its primary market is healthcare organisations—including hospitals and the NHS—while also serving other enterprises that require indoor localisation and workforce efficiency.